Blocking human enterovirus 71 replication by targeting viral 2A protease

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 12, 2012, Pages 2865-2869

  Falah, Nisrine ^a   Montserret, Roland ^a   Lelogeais, Virginie ^a   Schuffenecker, Isabelle ^b   Lina, Bruno ^a,b   Cortay, Jean Claude ^a   Violot, Sébastien ^a  

^a UNIVERSITÉ LYON 1   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Antiviral; Cysteine protease; Inhibitory peptide; Picornavirus

Indexed keywords

ANTIVIRUS AGENT; LUCIFERASE; RECOMBINANT ENTEROVIRUS 71 2A PROTEASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG TARGETING; ENTEROVIRUS 71; ENTEROVIRUS 71 INFECTION; ENTEROVIRUS INFECTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTHERMAL TITRATION CALORIMETRY; MOUSE; NONHUMAN; PROTEIN INTERACTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CYSTEINE ENDOPEPTIDASES; ENTEROVIRUS A, HUMAN; HELA CELLS; HUMANS; OLIGOPEPTIDES; PROTEASE INHIBITORS; PROTEIN BINDING; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84869407081     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks304     Document Type: Article

References (9)

1. Lin TY, Chang LY, Hsia SH et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 2002; 34 Suppl 2: S52-7.
2. Zhang Y, Zhu Z, Yang W et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 2010; 7: 94.
3. Chung YC, Ho MS, Wu JC et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008; 26: 1855-62.
4. Tung WS, Bakar SA, Sekawi Z et al. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther 2007; 5: 6.
5. Falah N, Violot S, Decimo D et al. Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2A protease. J Virol 2011; 86: 691-704.
6. Liebig HD, Ziegler E, Yan R et al. Purification of two picornaviral 2A proteinases: interaction with eIF-4 g and influence on in vitro translation. Biochemistry 1993; 32: 7581-8.
7. Baxter NJ, Roetzer A, Liebig HD et al. Structure and dynamics of coxsackievirus B4 2A proteinase, an enzyme involved in the etiology of heart disease. J Virol 2006; 80: 1451-62.
8. Wang QM, Johnson RB, Cox GA et al. Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli. J Virol 1998; 72: 1683-7.
9. Chan YF, Sam IC, AbuBakar S. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. Infect Genet Evol 2010; 10: 404-12.